End-of-day quote
Shanghai S.E.
18:00:00 2024-06-26 EDT
|
5-day change
|
1st Jan Change
|
18.94
CNY
|
-2.22%
|
|
-0.05%
|
-31.90%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,708
|
2,003
|
1,362
|
3,016
|
2,620
|
2,130
|
Enterprise Value (EV)
1 |
2,008
|
2,359
|
2,105
|
3,991
|
4,001
|
3,812
|
P/E ratio
|
31.8
x
|
32.8
x
|
36.7
x
|
30.5
x
|
-78.5
x
|
1,030
x
|
Yield
|
0.98%
|
0.93%
|
0.82%
|
0.67%
|
-
|
-
|
Capitalization / Revenue
|
1.64
x
|
1.6
x
|
1.11
x
|
1.57
x
|
0.82
x
|
0.8
x
|
EV / Revenue
|
1.93
x
|
1.88
x
|
1.71
x
|
2.08
x
|
1.25
x
|
1.43
x
|
EV / EBITDA
|
17.5
x
|
18.8
x
|
18.7
x
|
19.7
x
|
73.1
x
|
28.8
x
|
EV / FCF
|
-16.3
x
|
235
x
|
-5.57
x
|
-26.3
x
|
-8.16
x
|
-6.76
x
|
FCF Yield
|
-6.12%
|
0.43%
|
-17.9%
|
-3.8%
|
-12.3%
|
-14.8%
|
Price to Book
|
2.28
x
|
2.57
x
|
1.65
x
|
3.34
x
|
2.51
x
|
2.04
x
|
Nbr of stocks (in thousands)
|
73,354
|
73,355
|
73,357
|
72,518
|
76,563
|
76,574
|
Reference price
2 |
23.29
|
27.30
|
18.57
|
41.59
|
34.22
|
27.81
|
Announcement Date
|
19-03-04
|
20-02-17
|
21-04-29
|
22-04-06
|
23-04-20
|
24-04-26
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,039
|
1,254
|
1,230
|
1,916
|
3,211
|
2,666
|
EBITDA
1 |
115
|
125.7
|
112.7
|
203.1
|
54.77
|
132.6
|
EBIT
1 |
78.93
|
90.38
|
64.93
|
141.8
|
-8.206
|
39.31
|
Operating Margin
|
7.59%
|
7.21%
|
5.28%
|
7.4%
|
-0.26%
|
1.47%
|
Earnings before Tax (EBT)
1 |
55.71
|
67.4
|
39.18
|
104.3
|
-66.44
|
-21.28
|
Net income
1 |
53.75
|
61.13
|
37.17
|
102.1
|
-32.44
|
2.089
|
Net margin
|
5.17%
|
4.88%
|
3.02%
|
5.33%
|
-1.01%
|
0.08%
|
EPS
2 |
0.7328
|
0.8334
|
0.5066
|
1.365
|
-0.4362
|
0.0270
|
Free Cash Flow
1 |
-122.9
|
10.04
|
-377.7
|
-151.6
|
-490.5
|
-563.6
|
FCF margin
|
-11.83%
|
0.8%
|
-30.71%
|
-7.91%
|
-15.27%
|
-21.14%
|
FCF Conversion (EBITDA)
|
-
|
7.99%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
16.43%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.2280
|
0.2550
|
0.1520
|
0.2790
|
-
|
-
|
Announcement Date
|
19-03-04
|
20-02-17
|
21-04-29
|
22-04-06
|
23-04-20
|
24-04-26
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
299
|
356
|
742
|
975
|
1,381
|
1,683
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.603
x
|
2.835
x
|
6.586
x
|
4.8
x
|
25.22
x
|
12.69
x
|
Free Cash Flow
1 |
-123
|
10
|
-378
|
-152
|
-491
|
-564
|
ROE (net income / shareholders' equity)
|
7.4%
|
8.03%
|
4.82%
|
11.5%
|
-3.08%
|
0.42%
|
ROA (Net income/ Total Assets)
|
3.56%
|
3.76%
|
2.26%
|
3.94%
|
-0.19%
|
0.75%
|
Assets
1 |
1,511
|
1,626
|
1,648
|
2,590
|
17,210
|
277.1
|
Book Value Per Share
2 |
10.20
|
10.60
|
11.30
|
12.50
|
13.60
|
13.70
|
Cash Flow per Share
2 |
3.430
|
2.890
|
4.050
|
4.640
|
2.990
|
2.100
|
Capex
1 |
75.1
|
169
|
215
|
257
|
302
|
849
|
Capex / Sales
|
7.23%
|
13.51%
|
17.47%
|
13.39%
|
9.41%
|
31.85%
|
Announcement Date
|
19-03-04
|
20-02-17
|
21-04-29
|
22-04-06
|
23-04-20
|
24-04-26
|
|
1st Jan change
|
Capi.
|
---|
| -31.90% | 204M | | +20.77% | 68.72B | | -4.97% | 46.48B | | +24.89% | 44.63B | | +32.42% | 28.07B | | +8.74% | 19.25B | | +15.57% | 17.26B | | -12.49% | 15.12B | | -29.11% | 14.16B | | -31.12% | 12.22B |
Other Specialty Chemicals
|